Risk factors
Viridian Therapeutics (VRDN) risk factors
Item 1A of every Viridian Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors67 risks9 new7 dropped16 reworded
Viridian added multiple risks regarding FDA disruptions, healthcare compliance, and commercial marketing regulations.
Filed Feb 26, 2026 - FY2024 10-K risk factors65 risks
Viridian faces ongoing net losses and an accumulated deficit of $995.9 million, relying on $717.6 million in cash to fund operations into 2027.
Filed Mar 03, 2025